More I-O targets mean more shots on goal.
New report provides update on the fast moving, ever growing field of study in immuno-oncology. Full report in September Cancer Reviews Nature Discovery, Yu et al. Click on Charts to go to Article in Nature Reviews: "The number of active drugs in development has grown from 2,030 to 3,876, a 91% increase from 2 years ago. Among the six different drug classes, cell therapy represents the largest growth" - September Cancer Reviews Nature Discovery, Yu et al. Even more targets are
